How can molecular diagnostics contribute to the elimination of human African trypanosomiasis?

Philippe Büscher, Stijn Deborggraeve

Research output: Contribution to journalA1: Web of Science-article

Abstract

A variety of molecular diagnostic tests for human African trypanosomiasis (HAT) (sleeping sickness) has been developed. Some are effectively used for research and confirmation diagnosis in travel medicine, usually following non-standardized protocols. Others have become commercially available as diagnostic kits. WHO aims to eliminate HAT as a public health problem by the year 2020, and zero transmission by the year 2030. This article gives an overview of the recent progress in molecular diagnostics for sleeping sickness, including the most recent data on test performances. Also discussed is how molecular diagnostics can play an important role in the process toward the elimination of HAT.

Original languageEnglish
JournalExpert Review of Molecular Diagnostics
Volume15
Issue number5
Pages (from-to)607-615
Number of pages9
ISSN1473-7159
DOIs
Publication statusPublished - 2015

Fingerprint Dive into the research topics of 'How can molecular diagnostics contribute to the elimination of human African trypanosomiasis?'. Together they form a unique fingerprint.

Cite this